banner

A new way of investing

MARKETS

Sun Pharmaceuticals Industries Ltd

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

BSE

up-arrow 424.35  9.45 (2.28%) 

prev close()

414.90

open price()

418.90

Bid price()

-/-(×)

Ask price()

-/-(×)

volume

261,935

today's range()

429.90416.80

52 WK RANGE()

535.00350.40

NSE

up-arrow 424.55  9.50 (2.29%) 

prev close()

415.05

open price()

418.00

Bid price()

424.55(×5546)

Ask price()

0.00(×0)

volume

7,710,740

today's range()

430.00417.05

52 WK RANGE()

536.30344.55

Chart

Incorporation Year1993
Registered OfficeSun Pharma Advanced Res.Centre,Tandalja,Vadodara,Gujarat-390020
Telephone91-265-6615500
ChairmanIsrael Makov
Managing DirectorDilip S Shanghvi
RegistrarLink Intime India Pvt Ltd
C-101 247 Park ,L B S Marg ,Vikhroli West ,Mumbai-400083

Stock Summary

MARKET CAP (RS CR) 101,815.78
P/E 38.93
BOOK VALUE (RS) 98.33
DIV (%) 275.00
MARKET LOT 1.00
EPS (TTM) 10.90
PRICE/BOOK 4.32
DIV YIELD.(%) 0.65
FACE VALUE (RS) 1.00
DELIVERABLES (%) 21.09

Menu 1

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

About Company

Sun Pharmaceutical Industries Ltd. is the fifth largest speciality generic pharmaceutical company in the world. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates. The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams and liquids. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals.

The company has global presence with 41 manufacturing facilities across the world. India and the US are two predominant markets, accounting for nearly 70% of the company's revenue. The company has a robust product pipeline and established presence in Europe and high-growth emerging markets like Russia, Romania, South Africa, Brazil and Mexico. The company has entered into a join
Know More